CUAMC
China Universal Asset Management Company’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.41K | Buy |
25,032
+253
| +1% | +$75 | ﹤0.01% | 469 |
|
|
2025
Q1 | $8.53K | Sell |
24,779
-1,415
| -5% | -$487 | ﹤0.01% | 483 |
|
|
2024
Q4 | $37.5K | Buy |
+26,194
| New | +$37.5K | ﹤0.01% | 467 |
|
|
2023
Q4 | – | Sell |
-3,095
| Closed | -$3.93K | – | 464 |
|
|
2023
Q3 | $3.93K | Buy |
3,095
+1,596
| +106% | +$2.03K | ﹤0.01% | 403 |
|
|
2023
Q2 | $4.93K | Buy |
1,499
+36
| +2% | +$118 | ﹤0.01% | 372 |
|
|
2023
Q1 | $6.01K | Buy |
1,463
+449
| +44% | +$1.85K | ﹤0.01% | 345 |
|
|
2022
Q4 | $5.94K | Buy |
1,014
+104
| +11% | +$609 | ﹤0.01% | 278 |
|
|
2022
Q3 | $6K | Buy |
+910
| New | +$6K | ﹤0.01% | 256 |
|